Evidence map›Paper›PMID 19032583›Full record

ReviewAlcoholism, clinical and experimental research2009

Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.

Michael A Collins, Edward J Neafsey, Kenneth J Mukamal, Mary O Gray, Dale A Parks, Dipak K Das, Ronald J Korthuis

Abstract readReview
In one paragraph

Review in Alcoholism, clinical and experimental research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 4 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 4 syntheses or guidelines pooled it, 231 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Pretreatment alcohol drinking goals are associated with treatment outcomes.Alcoholism, clinical and experimental research · 2013
    Trial
  7. Trial
  8. Article
  9. Article
  10. Protective Effect ofFood science & nutrition · 2026
    Article
  11. Observational
  12. Evidence triangulation in health research.European journal of epidemiology · 2025
    Article
  13. Review
  14. Observational
  15. Article
  16. Review
  17. Review
  18. Neuroimaging-Derived Predicted Brain Age and Alcohol Use Among Community-Dwelling Older Adults.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023
    Observational
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Michael A CollinsDepartment of Cell Biology, Neurobiology & Anatomy, Loyola University Chicago Stritch School of Medicine, 2160 S. 1st Avenue, Maywood, IL 60153, USA. mcollin@lumc.edu
Edward J Neafsey
Kenneth J Mukamal
Mary O Gray
Dale A Parks
Dipak K Das
Ronald J Korthuis
San Francisco General Hospital · USBeth Israel Deaconess Medical Center · USLoyola University Chicago · USUniversity of Alabama at Birmingham · USUniversity of Connecticut · US

Funding

VASCULAR REACTIVITY FOLLOWING ISCHEMIA-REPERFUSIONP01DK043785 · NIDDK · LOUISIANA STATE UNIV HSC SHREVEPORT · PI GRANGER, D. NEIL · 1991 to 2011
$17.0M
PROTECTION FROM CARDIAC REPERFUSION INJURY BY ETHANOLR01AA011135 · NIAAA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI GRAY, MARY O · 1996 to 2006
$1.8M
Ethanol Prevents Microvascular DysfunctionR01AA014945 · NIAAA · UNIVERSITY OF MISSOURI-COLUMBIA · PI KORTHUIS, RONALD JOHN · 2006 to 2010
$1.6M
HIV-1 protein neurotoxicity and ethanol pre-conditioningR01AA013568 · NIAAA · LOYOLA UNIVERSITY CHICAGO · PI COLLINS, MICHAEL A. · 2003 to 2006
$1.2M
Effects of Ethanol on Microglial Chemokine SignalingF31AA013361 · NIAAA · LOYOLA UNIVERSITY CHICAGO · PI SCHIPMA, MATTHEW J · 2001 to 2003
$61k
ALCOHOL AND HIV1 GP120 INDUCED BRAIN DAMAGER01AA011723 · NIAAA · LOYOLA UNIVERSITY CHICAGO · PI COLLINS, MICHAEL A · 1997 to 1999
–
NIAAA NIH HHS AA 011723NIAAA NIH HHS AA 013568NIAAA NIH HHS AA 014945NIAAA NIH HHS AA 11135NIAAA NIH HHS AA 13361NIAAA NIH HHS F31 AA013361NIAAA NIH HHS R01 AA011135NIAAA NIH HHS R01 AA013568NIAAA NIH HHS R01 AA014945NIDDK NIH HHS P01 DK043785
6 · The paper itself

Abstract

In contrast to many years of important research and clinical attention to the pathological effects of alcohol (ethanol) abuse, the past several decades have seen the publication of a number of peer-reviewed studies indicating the beneficial effects of light-moderate, nonbinge consumption of varied alcoholic beverages, as well as experimental demonstrations that moderate alcohol exposure can initiate typically cytoprotective mechanisms. A considerable body of epidemiology associates moderate alcohol consumption with significantly reduced risks of coronary heart disease and, albeit currently a less robust relationship, cerebrovascular (ischemic) stroke. Experimental studies with experimental rodent models and cultures (cardiac myocytes, endothelial cells) indicate that moderate alcohol exposure can promote anti-inflammatory processes involving adenosine receptors, protein kinase C (PKC), nitric oxide synthase, heat shock proteins, and others which could underlie cardioprotection. Also, brain functional comparisons between older moderate alcohol consumers and nondrinkers have received more recent epidemiological study. In over half of nearly 45 reports since the early 1990s, significantly reduced risks of cognitive loss or dementia in moderate, nonbinge consumers of alcohol (wine, beer, liquor) have been observed, whereas increased risk has been seen only in a few studies. Physiological explanations for the apparent CNS benefits of moderate consumption have invoked alcohol's cardiovascular and/or hematological effects, but there is also experimental evidence that moderate alcohol levels can exert direct "neuroprotective" actions-pertinent are several studies in vivo and rat brain organotypic cultures, in which antecedent or preconditioning exposure to moderate alcohol neuroprotects against ischemia, endotoxin, beta-amyloid, a toxic protein intimately associated with Alzheimer's, or gp120, the neuroinflammatory HIV-1 envelope protein. The alcohol-dependent neuroprotected state appears linked to activation of signal transduction processes potentially involving reactive oxygen species, several key protein kinases, and increased heat shock proteins. Thus to a certain extent, moderate alcohol exposure appears to trigger analogous mild stress-associated, anti-inflammatory mechanisms in the heart, vasculature, and brain that tend to promote cellular survival pathways.

Indexed as

Cardiotonic AgentsNeuroprotective AgentsAlcohol DrinkingAnimalsAntioxidantsCardiovascular DiseasesCentral Nervous System DepressantsDementiaEthanolHumansNitric OxideProtein Kinase CResveratrolStilbenesAntioxidantsCardiotonic AgentsCentral Nervous System DepressantsEthanolNeuroprotective AgentsNitric OxideProtein Kinase CResveratrolStilbenes

Identifiers

PMID19032583
PMCPMC2908373
OpenAlexW2111348890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.